(Q64908003)

30 June 2019

title

The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas. (English)

1 reference

30 June 2019

1 reference

1

1 reference

30 June 2019

Jesus M. Paramio

5

1 reference

30 June 2019

Cristina Sánchez

7

1 reference

30 June 2019

author name string

C Andradas

2

1 reference

30 June 2019

J M Flores

3

1 reference

30 June 2019

M Quintanilla

4

1 reference

30 June 2019

M Guzmán

6

1 reference

30 June 2019

language of work or name

English

0 references

publication date

2 July 2012

1 reference

30 June 2019

published in

Oncogene

1 reference

30 June 2019

volume

32

1 reference

30 June 2019

issue

20

1 reference

30 June 2019

page(s)

2534-2542

1 reference

30 June 2019

https://scigraph.springernature.com/pub.10.1038/onc.2012.278

exact match

0 references

cites work

Identification of GPR55 as a lysophosphatidylinositol receptor

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Elevated levels and mitogenic activity of lysophosphatidylinositol in k-ras-transformed epithelial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Release of the mitogen lysophosphatidylinositol from H-Ras-transformed fibroblasts; a possible mechanism of autocrine control of cell proliferation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

A role for endoglin as a suppressor of malignancy during mouse skin carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Activation of MAP kinase signaling through ERK5 but not ERK1 expression is associated with lymph node metastases in oral squamous cell carcinoma (OSCC).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

G-protein-coupled receptors and cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

G protein-coupled receptors: novel targets for drug discovery in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

LPA receptors: subtypes and biological actions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Autotaxin and LPA receptor signaling in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

The enigmatic pharmacology of GPR55

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non-tumour brain tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Anandamide and other N-acylethanolamines in human tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Possible endocannabinoid control of colorectal cancer growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: over-expression of the high-affinity receptor edg4 in differentiated thyroid cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Lysophosphatidic acid is a bioactive mediator in ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

LPA2 receptor mediates mitogenic signals in human colon cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Differential expression of lysophosphatidic acid receptor-2 in intestinal and diffuse type gastric cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: relevance to prostate cancer and benign hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.278

31 March 2020

Identifiers

DOI

10.1038/ONC.2012.278

1 reference

30 June 2019

Dimensions Publication ID

1001483549

0 references

1 reference

30 June 2019